CSF Proteomic Alzheimer's Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals

B.M. Tijms*, J. Gobom, C. Teunissen, V. Dobricic, M. Tsolaki, F. Verhey, J. Popp, P. Martinez-Lage, R. Vandenberghe, A. Lleo, J.L. Molinuevo, S. Engelborghs, Y. Freund-Levi, L. Froelich, L. Bertram, S. Lovestone, J. Streffer, S. Vos, K. Blennow, P. ScheltensH. Zetterberg, P.J. Visser, A.D.N.I. ADNI, Alzheimer's Disease Neuroimaging Initiative

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Web of Science)
Original languageEnglish
Article number36
Number of pages15
JournalProteomes
Volume9
Issue number3
DOIs
Publication statusPublished - 1 Sep 2021

Keywords

  • Alzheimer's disease
  • cerebrospinal fluid proteomics
  • risk factors
  • cognitive functioning
  • amyloid beta
  • tau
  • ASSOCIATION WORKGROUPS
  • DIAGNOSTIC GUIDELINES
  • NATIONAL INSTITUTE
  • RECOMMENDATIONS
  • IMPAIRMENT
  • REST
  • BIOMARKERS
  • DEMENTIA
  • CRITERIA
  • NEURONS

Cite this